BioMimetic Therapeutics (BMTI) Posts Q1 Loss of 22c
Tweet
Share
E-mailGet Alerts BMTI Hot Sheet
Price: $9.49 --0%
Financial Fact:
Depreciation and capital lease amortization: 233.35K
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Depreciation and capital lease amortization: 233.35K
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
BioMimetic Therapeutics, Inc. (Nasdaq: BMTI) reported Q1 EPS of ($0.22), versus ($0.28) reported last year. Revenue for the quarter came in at $466.38 million, versus $398.7 million reported last year.
For earnings history and earnings-related data on BioMimetic Therapeutics, Inc. (BMTI) click here.
For earnings history and earnings-related data on BioMimetic Therapeutics, Inc. (BMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
- Motorsport Games Inc. (MSGM) Tops Q2 EPS by 33c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
